Twist Bioscience (TWST)
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products.
If you are interested in TWST stock information, you might also be interested in competitors like NasdaqGS:GH.
With a P/E ratio of 0.00, the stock appears relatively cheap compared to its index ^SPX at the moment.
The market capitalization of Twist Bioscience is currently at $2.12 B. This places it among the medium capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 2.45.
With one share of Twist Bioscience investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.
For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.11. The price of the stock NasdaqGS:TWST is therefore subject to relatively strong fluctuations in relation to the overall market.
4.12% of TWST Stocks is owned by insiders.
For Wall Street analysts, a price target of $111.83 is currently considered realistic.
NasdaqGS:TWST has a 52 week range of $25.07 - $139.99 and is currently trading around $37.58.
The high short sale ratio indicated that the value might decrease in the foreseeable future.